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Abstract 
 
INNATE LYMPHOCYTES IN YOUNG MICE PROMOTE PROTECTION AGAINST 
PLASMODIUM CHABAUDI INFECTION 
 
 
Lyndsay Blake Richard 
B.S., Appalachian State University 
M.S., Appalachian State University 
 
 
Chairperson: Dr. Michael M. Opata 
 
 
Understanding the immune response to malaria, especially in children under five, is 
limited due to the lack of a reliable animal model to study the pathogenesis of the disease. By 
utilizing a newly developed young rodent model in our lab, we have observed that both 
splenocytes and purified CD4+ T cells from 8-week adult mice proliferate faster than day 15 old 
young mice (pups) when stimulated with a plate bound anti- CD3 and CD28 in vitro. Using 
adoptive transfer technique, we show that both pup and adult cells protect immunocompromised 
RAG1 knockout (RAG1KO) mice from death.  To better understand the responsive and 
protective cell populations in the splenocytes from the young mice, we adoptively transferred 
splenocytes from both pups and adult mice into RAG1KO mice and infected the recipients with 
P. chabaudi to determine both innate and adaptive immune cell populations. We observed higher 
numbers and proportions of innate lymphocytes including gamma delta (γδ) T cells and natural 
killer (NK) cells in the pup splenocyte recipients when compared to adult counterparts on day 9 
post-infection. In contrast, there were significantly higher proportions of macrophages in the 
adult splenocyte recipients. Taken together, our findings suggest that pup splenocytes are 
enriched with innate lymphocytes that may promote protection against P. chabaudi infection. 
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Chapter 1 
INTRODUCTION 
 
Throughout history, malaria has proved to be a significant threat to human health, and 
300–500 million people have a malarial illness annually (1). Despite extensive strides towards 
reducing the progress of infection, malaria continues to inflict extensive morbidity and mortality 
in resource-limited countries, particularly in sub-Saharan Africa.  
Malaria is caused by protozoan parasites of the genus Plasmodium. There are five 
parasite species known to infect humans including Plasmodium falciparum, P. vivax, P. 
malariae, P. ovale, and P. knowlesi (2). However, the vast majority of malaria related deaths are 
caused by P. falciparum (3). Transmission of Plasmodium parasites to the mammalian host 
begins with the deposition of the infectious, motile sporozoites into the human skin by a bite 
from an infected female Anopheles mosquito as it takes a blood meal. The sporozoites traverse 
through the skin to capillaries, where they gain access to the bloodstream and get transported to 
the liver (4, 5). In the liver, each individual sporozoite infects a healthy hepatocyte (liver cell), 
then transforms and undergoes growth, and genome replication (4). In both humans and rodents, 
merozoites are released from the liver into the bloodstream 7–10 days after initial transmission. 
The liver stage is predominately asymptomatic, and the host is generally unaware of the fact that 
they are already infected with malaria. As merozoites are released from the liver, they infect red 
blood cells (iRBCs), replicate within, and are released again to undergo continuous cycles of 
infection and replication. This continuous release cycles allow parasite numbers to reach billions 
within a week (6, 7). 
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The clinical manifestations of malaria, and severity of  clinical attack depends on the 
species and strain of the infecting Plasmodium parasite, as well as the person’s age, immune 
status, malaria specific immunity, nutritional status, and the mode of transmission (8). The first 
clinical symptoms and awareness of malaria infection are observed during the rupture of the 
schizont, which initiates the symptomatic blood-stage of malaria infection. Upon merozoite 
infection of the red blood cells, the merozoites form the trophocyte (ring form), which later fully 
develop into late blood-stage schizonts. The rupturing of the blood-stage schizonts inside the 
infected red blood cells releases on average of 15 to 32 merozoite progeny that infect 
surrounding red blood cells (9, 10). The most well-known clinical manifestations in human 
infection are anemia fever, impaired consciousness, seizures, vomiting, and respiratory distress. 
In children, features of severe P. falciparum can include severe sepsis and cerebral malaria [8].  
Children between six months and five years of age are at highest risk of malaria disease 
due to loss of maternal immunity. At this age, children have not yet developed specific immunity 
to malaria, and therefore rely heavily on a rapid, robust, and non-specific immune response in 
order to quickly counter the progression of malaria pathology and infection. The initial 
inflammatory response by the innate immune cells is critical in quickly combating malaria 
infection. It does this by (i) acting rapidly as a first line of defense in which it clears the parasite 
early, thus inhibiting its progressive growth, and (ii) initiating the adaptive immune response and 
subsequently leading to the control of re-infection. The innate immune response in P. falciparum  
infection is orchestrated by macrophages, innate lymphocytes (natural killer cells), and innate-
like lymphocytes (gamma delta T cells), due to their ability to directly sense the presence of the 
parasite through specific innate immune mechanisms (11).  
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Natural killer (NK) cells contribute to providing a first line of defense against pathogens 
through their ability to respond to a pathogenic challenge prior to antigen presentation and 
recognition (12). This is particularly important in children, due to their naive and still developing 
immune system. Despite being relatively non-specific, NK cells have an array of innate cell 
receptors to “sense” their environment (13). NK cells control infection through the robust 
production of pro-inflammatory cytokines and the direct destructions of damaged, dysfunctional, 
or infected host cells through cytotoxic activity (12). In malaria-infected children, elevated NK 
cell counts, and increased NK cell cytotoxicity have been correlated with lower parasitemia. This 
is due to the observed ability of NK cells to directly lyse Plasmodium-infected red blood cells, 
and are also one of the earliest sources of IFN-γ following P. falciparum  infection (14). In order 
for this to take place, NK cells require activation signals from three sources: (i) priming by IL-2 
or IL-15, which is produced and released by T cells or dendritic cells (DCs) respectively, (ii) IL-
12 or IL-15 from macrophages, or (iii) from direct cell-to-cell contact with macrophages (11). 
Gamma delta (γδ) T cells are an unconventional T cell subset, which only constitute 2-
5% of the total circulating lymphocytes, γδ T cells play an integral role in both the innate and 
adaptive arms of the immune system. γδ T cells are the first T cells to arise during fetal 
development and provide a protective function even prior to birth (15). However, the percentage 
of this population declines after birth and only constitutes 0.5% of all mature T cells in adults 
(15). These cells have long been known to rapidly proliferate in both humans and mice following 
primary malaria infection (16, 17), with many of their functions including: robust production of 
inflammatory, cytotoxic killing, and immune cell recruitment (16-18). γδ T cells cytotoxic killing 
heavily contributes toward antiparasitic activity through the secretion of cytotoxic molecules 
perforin, granzyme A and B, and Fas-Ligand/CD95L expression (18, 19), as well as 
 
 
4 
inflammatory cytokines (IFN-γ, TNF- and TNF-/LT). All of which work in concert with other 
mechanisms in order to directly eliminate parasite, mediating protection against recrudescence 
and/or reinfection, particularly in the context of malaria (20), and lead to the recruitment of other 
immune cells (18, 19).  
The prevalence of IFN-γ production by immune cells has been associated with a greater 
likelihood of uncomplicated malaria (8), as well as reduced severe malarial anemia (9). 
Importantly, experiments in mice have demonstrated that IFN-γ production by both NK and γδ T 
cells play a major role in the direct control of Plasmodium infection through the recruitment of 
other key players in the immune response to malaria disease. The IFN- is specifically involved 
in the activation of macrophages, which control parasite through phagocytosis and the 
production of other inflammatory mediators and reactive oxygen species (ROS).  
Macrophages play an indispensable role during malaria infection through antigen 
recognition, processing, and presentation (21). Interactions between these cell subsets 
and Plasmodium parasites occur at every stage of infection (22, 23). P. falciparum is 
predominately found in the blood-stage and provides many opportunities for antigen presenting 
cells (APCs) to interact with the Plasmodium parasites, therefore leading to the internalization 
(phagocytosis) of the merozoites and whole parasitized erythrocytes in both an opsonization-
dependent and opsonization-independent manner (11, 24). This allows for antigen processing 
and presentation to T cells via the major histocompatibility complex II (MHCII) (23, 25).  
Another function of macrophages is their ability to kill parasite through secretory 
products. After erythrocyte invasion by merozoites, major transformations are induced on the 
surface of iRBCs, which can directly interact with receptors on the surface of macrophages (21, 
26). In response to infection caused by Plasmodium parasites, macrophages release antimicrobial 
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reactive oxygen species (ROS) and proinflammatory cytokines and chemokines (TNF-, IL-1, 
and IL-6), which are highly damaging and lead to efficient killing of iRBCs (12, 27). This 
generation of ROS causes an imbalance with antioxidant species, that triggers oxidative stress, 
which is an important response to infections (28-30). In the case of malaria, parasite control is 
caused by oxidative damage to both the parasite as well as parasitized erythrocytes, which takes 
place once ROS are able to diffuse through the membrane of infected red blood cells (28, 29). 
The innate immune response provides a critical mechanism for the rapid sensing, 
elimination, and control of the chronic pathology associated with P. falciparum infection. 
However, the adaptive immune response provides a more slowly developed, more specific, and 
fine-tuned repertoire of recognition for both self- and non-self-antigens (31, 32). Adaptive 
immunity involves a highly controlled and regulated communication between APCs, T cells, and 
B cells. All working in tandem in order to orchestrate and facilitate pathogen-specific pathways, 
generation of memory, and regulation of the host immune response (31). It is important to note 
that sterile immunity to malaria is never achieved by the host (3). But after repeated exposures to 
the infection, individuals eventually develop effective partial immunity that controls parasitemia 
and prevents severe and life-threatening complications (31).  
Despite considerable efforts to control malaria over decades, there has yet to be a highly 
effective vaccine for any of the five plasmodial species which cause human malaria. This is 
predominately due to the plasmodial life cycle being incredibly complex, and thus the task of 
designing an effective vaccine has been difficult (4). In addition to the insufficiently understood 
parasite biology, malaria infection is currently undergoing a worldwide resurgence because of 
the spread of drug resistant parasite strains and increasing resistance of mosquitoes to 
insecticides. Several molecules from the sporozoite at the hepatocyte or asexual erythrocyte, and 
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gametocyte stages have been identified and studied as potential vaccine candidates with the aim 
of eliciting protection against infection, clinical illness, and/or transmission of malaria, but none 
has so far been highly effective (33). Thus, the lack of an effective vaccine necessitates intensive 
research on human malaria parasites that can inform the development of new intervention tools 
(34). 
There are currently three developed strategies implemented by the World Health 
Organization (WHO) for protection and development of acquired protective immunity to P. 
falciparum infection in young African children: (i) insecticide-treated bed nets, (ii) preventive 
therapy, and (iii) anti-sporozoite vaccines [35]. Resistance has now been detected in malaria 
vectors to the four classes of public health insecticides used in malaria vector control 
(pyrethroids, organochlorines, organophosphates and carbamates), which are components in 
insecticide-treated bed nets. 
Most current vaccine candidates target a single stage of the parasite’s life cycle and 
vaccines against the early pre-erythrocytic stages have shown most success (36). Vaccines based 
on the pre-erythrocytic stages usually aim to completely prevent infection, while blood stage 
vaccines aim to reduce (and preferably eliminate) the parasite load once a person has been 
infected (37). Gametocyte vaccines would prevent the parasite being transmitted to others 
through mosquitoes. Overall, an ideal vaccine would be effective against all parasite stages. The 
ultimate goal of developing a vaccine for malaria is to ensure complete cure, through the rapid 
and full elimination of the Plasmodium parasite from the patient’s blood, in order to prevent 
progression of uncomplicated malaria to severe disease, as well as prevent the chronic infection 
that leads to malaria-related anemia as well as death. 
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The most current and promising vaccine design is the RTS, S, which was recently 
approved for use in some African countries (38). It is a malaria recombinant vaccine, that is 
structured on the foundation of the hepatitis B surface antigen virus-like particle (VLP or 
HBsAg), and is genetically-engineered to include the carboxy terminus (amino acids 207-395) of 
the circumsporozite antigen (CSP) (33, 38). CSP is a malaria parasite sequence that is species-
specific, but highly conserved for isolates from each of the five species of Plasmodium (39). 
The RTS, S vaccine accomplishes limited protection against the Plasmodium 
circumsporocyte, and its ability to illicit the production of anti-CSP antibodies by plasma cells. It 
also leads to activation of antigen specific CD4+ T cells which can provide immunogenicity with 
or without boosters (40). RTS, S induces very high immunoglobulin G (IgG) concentrations and 
moderate to high CD4+ T cell responses in vaccinated humans (33). Protection by the RTS, S 
vaccine varies from 12 to 68% efficacy in the first year but has been shown to degrade to only a 
2.5% efficacy after four years (41).  The limited efficacy of this vaccine may be due to the 
selective and minimal immune responses that it induces, which consists mostly of antibodies 
against the repeat domain of the CSP and are known to neutralize and halt the progression of 
sporozoites in the liver (33, 42). An additional limitation of the RTS, S vaccine is that it does not 
induce CD8+ T cell responses, as these cells are known to be effective and have efficient anti-
parasite mechanisms that eliminates malaria during the liver stages (33, 42).  The development of 
a vaccine capable of inducing CD8+ T cell responses in addition to antibodies may require major 
changes in the design of the vaccine construct of the RTS, S in order for it to fully illicit an 
effective protective immune response against P. falciparum (33, 42). 
Studying the protective host responses against the Plasmodium parasite has emerged as a 
key factor in reducing morbidity and mortality associated with severe infections. This is 
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particularly important early in the infection as well as for susceptible groups who are most likely 
to succumb to infection. This study aligns with this goal in that understanding malaria responsive 
cells early in life can inform better vaccine designs that are protective to the vulnerable 
population. Therefore, we use an adoptive transfer technique to better understand Plasmodium 
responsive cells in young and adult mice. We hypothesize that young mice have more innate like 
lymphocytes (γδ T and NK cells) that promote protection against malaria in P. chabaudi 
infection. 
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Chapter 2 
MATERIALS AND METHODS 
Mice and Parasite 
Adult C57BL/6 mice were obtained from Harlan labs, and Recombinant Activating Gene 
knockout mice (RAG1KO) that are immunocompromised, were obtained from The Jackson 
laboratories. All mice were maintained at Appalachian State University as breeding pairs and kept 
on a 12:12 light/dark cycle. We utilized the rodent strain of malaria, Plasmodium chabaudi (P. 
chabaudi), which manifests disease symptoms that are similar to that caused by the human parasite 
strain Plasmodium falciparum (P. falciparum), such as a synchronized life cycle, pathology and 
long-term chronic infection. The parasite was a gift from Dr. Robin Stephens from the University 
of Texas Medical Branch at Galveston with permission from Dr. Jean Langhorne (Francis Creek 
Institute, UK). Parasites were counted by light microscopy after Diff Quick staining. 
 
In vitro cultures 
Splenocytes were collected from days 10, 15 and adult 8-week old mice that were not 
infected. Single cell suspensions were obtained by homogenization of the spleens through a cell 
strainer, and red blood cells were lysed using red blood cell lysis buffer (Tonbo Biosciences, San 
Diego, CA). Cells were washed with PBS and resuspended in complete ISCOVES culture media 
supplemented with 2 mM L-glutamine, 5mM sodium pyruvate, non-essential amino acids (MEM 
NEAA), 10 mM HEPES, 100 U/ml Penicillin, 100 U/ml Streptomycin and 25 M 2-
Mercaptoethanol. Cells were counted using a hemocytometer and trypan exclusion. After 
counting aliquots for culture were labeled with CFSE according to the manufacturer’s 
instructions (Tonbo Bioscience) and then cultured in anti-CD3/CD28 bound 24 well plates at a 
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concentration of 5x105 cells/well. Proliferation was determined at 2- and 4-days post-culture by 
determining CFSE intensity. 
 
Age Determination  
The average lifespan of laboratory mice is about 24 months, whereas the life expectancy of 
humans globally is about 80 years. Therefore, considering both lifespans, the ages of mice were 
calculated as follows utilizing a murine to human age equivalency calculation determined by 
Dutta and Sengupta [43]: 
 
(80 ×  365)
(2 × 365)
 = 40 ℎ𝑢𝑚𝑎𝑛 𝑑𝑎𝑦𝑠 = 1 𝑚𝑜𝑢𝑠𝑒 𝑑𝑎𝑦 
 
365 
40
= 9.125 𝑚𝑜𝑢𝑠𝑒 𝑑𝑎𝑦𝑠 = 1 ℎ𝑢𝑚𝑎𝑛 𝑦𝑒𝑎𝑟 
 
Therefore, when utilizing these calculations 1 human year is approximately equivalent to 9 
mouse days when considering entire lifespan of both species. We used C57BL/6 10 and 15-day-
old pups and 8-week-old adult mice.  
 
Adoptive Transfers 
Both C57BL/6 15-day-old pups and 8-week-old adult mice were euthanized, and spleens 
were harvested. Single cell suspensions were obtained, and RBCs were lysed as described above. 
After counting, splenocytes were transferred at a concentration of 2x107 intraperitonially into 
immunocompromised RAG1KO mice. The recipient mice of either pup or adult cells were 
inoculated with 1x105 Plasmodium infected red blood cells (iRBCs) one day post-transfer. On 
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day 9 post-infection, tail blood smears were collected for parasite determination in the recipient 
RAG1KO mice before they were sacrificed to determine immune cells in the spleens as shown in 
the schematic in Figure 1 below.  
 
FIGURE 1. Schematic for RAG1 KO adoptive transfer and timeframe. RAG1 KO mice received 
purified splenocytes from either pup (15- day- old) or adult (8- week- old) C57BL/6 mice at a 
concentration of 2x107 cell/mouse. One day post transfer the RAG1 KO were inoculated with a parasite 
dosage of 1x105. Mice were then sacrificed 9 days post-infection (d.p.i).Pcc = Plasmodium chabaudi 
 
 
Determining Parasitemia 
Parasite burden was determined using thin blood smears that were obtained through tail snips 
of infected mice at day 9 post-infection. The slides were stained with Diff-Quick and parasites 
were counted under a light microscope in 10 to 50 different fields, depending on the level of 
anemia/parasite load. To determine percent parasitemia, the number of infected red blood cells 
were divided by the total number of red blood cells (both infected and un-infected) in all 
counted fields. The outcome was then multiplied by 100 to get a percentage value as shown in 
the formula below: 
 
Splenocytes
Splenocytes
9 d.p.i
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% 𝑃𝑎𝑟𝑎𝑠𝑖𝑡𝑒𝑚𝑖𝑎 =  
𝑖𝑅𝐵𝐶
𝑇𝑜𝑡𝑎𝑙 𝑅𝐵𝐶
  × 100 
 
Flow cytometry  
a) Surface staining 
Aliquots were taken from the single cell suspension after processing from the spleens as 
described above. The cells were counted with the use of a hemocytometer and an aliquot of 
3x106 cells/mL was transferred into polystyrene round-bottom tubes and washed in cold FACS 
buffer (PBS, 2% FBS, and 0.1% NaN3 sodium azide). The cells were then incubated with Fc 
receptor blocking antibody for 20 minutes. After this incubation, florescent antibody stain master 
mix was added directly to the tubes and incubated for an additional 40 minutes for surface 
molecule staining. The master mix was made with the following fluorescently conjugated 
antibodies: CD4+ T cell panel (CD4, CD44, CD62L, CDlla), Gamma Delta T cell panel (CD3, 
), Macrophage panel (CDllb, F4/80, MHCII, MHCI, CD86), and Natural Killer cells (NK) 
panel (CD49, NK1.1). Stained cells were then washed and resuspended in FACS buffer for flow 
cytometry analysis after filtration with nanomesh screens. 
 
b) Intracellular staining 
After preparation of spleen cells as described above, splenocytes were incubated in complete 
Iscoves media (described in the in vitro section).  A stimulation cocktail of phorbol 12-myristate 
13-acetate (PMA), ionomycin and Brefeldin A (Tonbo Biosciences) was added to each well, 
except for an unstimulated control. Treatment with PMA and ionomycin is sufficient to induce 
activation of many cell types to produce cytokines. After 4 hours incubation, cells were 
harvested and washed with FACS buffer. Cells were Fc blocked and then immediately stained 
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for surface markers. The cell membrane was stabilized with 2% paraformaldehyde (PFA) and 
permeabilized with a perm wash buffer (Tonbo Biosciences). The cells were then stained with 
anti-IFN-, TNF, IL-2 and IL-10, or perforin, and granzyme B, then incubated for 30 minutes. 
Stained cells were then washed three times with perm wash buffer to remove excess unbound 
antibodies and filtered as mentioned above for flow analysis. 
 
Data Analysis 
All flow cytometry data were collected on an FC500 Beckman Coulter flow cytometer 
(Indianapolis, IN). Cytometry data was analyzed with FlowJo8 software (Ashland, OR) and data 
calculations were done using Microsoft excel. Graphs and statistical evaluations were done using 
the Student’s t test to compare distribution of pairs of groups in Prism GraphPad (San Diego, 
CA). In some experiments that include four-group comparisons, a non-parametric One-way 
ANOVA was used followed by comparison among individual groups. A p value of <0.5 was 
considered significant. 
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Chapter 3 
 
RESULTS 
 
 
Previous results from our laboratory showed that when splenocytes from young mice are 
transferred into immunocompromised RAG1KO knockout mice (RAG1KO), the 
immunocompromised mice are protected from death and these mice regain weight better than 
adult cell recipients after the peak of infection (Smith, et al., unpublished data). This suggested 
to us that the splenocytes from young mice contained cell populations that could confer 
protection against malaria infection. In order to investigate this further, we determined the 
proliferation capacity of the young versus adult cells. We harvested spleen cells from 10, and 15- 
days old young or adult 8-week old mice, then cultured them in vitro on plate bound anti-
CD3/CD28, to selectively stimulate T cell proliferation and expansion.  
We observed that both the young and adult splenocytes proliferated as measured by 
CFSE dilution. As expected, the adult splenocytes proliferated faster on days 2 and 4 than the 
cells from both 10 and 15-days young mice. Comparing only the pup cells, 15-days old 
splenocytes proliferated faster than the 10-day pup cells (Fig. 2 A & B). Based on the 
proliferation pattern of these splenocytes, we concluded that as the mice grow, their cells have 
the potential to proliferate faster. 
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FIGURE 2. Adult splenocytes proliferate faster than young mice splenocytes. Splenocytes from 
young 10 days old (green), or 15 days old (blue), and 8-week old adult (orange) C57BL/6 mice were 
labeled with CFSE and cultured in vitro. Cells were harvested on (A) day 2 and (B) day 4 post stimulation 
with plate bound anti-CD3/CD28 to determine proliferation by CFSE dilution. (Red) indicate CFSE 
labeled control cells that were not cultured. 
 
 
To better understand the responsive immune cells in young mice infected with malaria, 
we infected 15 days old pups or 8 week old adult mice with 1x105 P. chabaudi and determined 
activation of CD4+ T cells and presence of  T cells, which are known to be highly present in 
young mice, as well as children in human studies [44]. There was no significant difference in the 
percentage of activated CD4+ T cells between infected pups and adult mice, but due to larger 
spleen sizes, cell numbers were higher in adult mice (Fig. 3A & B). We also observed 
significantly higher proportions and numbers of  T cells in the adult than young mice (Fig. 4A 
& B). Taken together, these results suggest that in the physiological environment, there is higher 
numbers of both activated CD4+ T cells as well as  T cells in the adult mice.  
 
A
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%
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ax
B
Control
D10 Pup
D15 Pup
Adult
 
 
16 
 
FIGURE 3. Numbers but not proportions of activated CD4 T cells are higher in adult mice. 
C57BL/6 15-day old pups and 8-week-old adult mice were infected with 1x105 P. chabaudi and sacrificed 
on day 8 post-infection. Activation of CD4+ T cells was determined using surface markers CDlla, CD62L, 
CD44 antibodies. (A) Percent and (B) number of activated CD4+ T cells was determined with flow 
cytometry. These data represent 3-7 mice per group from 2 independent experiments. Error bars represent 
SEM and significance was determined using One-way Anova. ** p < 0.01, *** p <0.001, **** p 
<0.0001. 
 
 
 
 
 
 
 
 
FIGURE 4. Proportions and numbers of  T cells are higher in adult mice. C57BL/6 15-day old 
pups and 8-week-old adult mice were infected with 1x105 P. chabaudi and sacrificed day 8 post-infection. 
The  T cells were determined using anti- CD3 and  antibodies.  (A) Percent and (B) number of  T 
cells was determined by flow cytometry. Data represent 3-7 mice per group from 3 independent 
experiments. Error bars represent SEM and significance was determined by One-way Anova. *p < 0.05, 
** p < 0.01, *** p <, **** p <0.0001. 
 
 
 
A B
Pups Adults Pup Cntrl Adult Cntrl
0
2
4
6
8
%
C
D
3
 +
 
+
** *
**
Pups Adults Pup Cntrl Adult Cntrl
0
5.0
1.0
1.5
2.0
2.5
#
 C
D
3
 +
 
+
 (
1
0
5
)
****
****
****
 
 
17 
 
Pup splenocytes reduce parasitemia in immunocompromised mice infected with malaria. 
Since young mice have a naive immune system that is still developing, the results from 
the infection of the pups and adult mice in Figures 3 and 4 above may be biased in favor of the 
adult mice due to a fully developed immune system and bigger spleens. To address this concern, 
we performed an adoptive transfer of the splenocytes from both pups and adult mice into RAG1 
KO recipient mice, which do not produce mature T or B cells, and therefore lack an adaptive 
immune system [45, 46]. But it is important to note that RAG1KO still retain their own innate 
immune cell populations prior to an adoptive transfer. 
The recipient mice were infected with 1x105 P. chabaudi one day after cell transfer and 
sacrificed 9 days post-infection. When looking at the demonstrable presence of parasite in the 
blood (parasitemia) at the peak of infection (day 9), we observed that RAG1 KO mice that had 
received splenocytes from either adult or young mice had significantly lower percent parasitemia 
when compared to the no cell controls, but both pups and adult cell recipients had similar 
reduction in parasitemia (Fig. 5A). Recipients of both pup and adult spleenocytes also retained 
their weight when compared to no cell control mice which lost significantly more weight 
between 7-9 days post infection. 
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Figure 5. Both adult and pup cells reduce parasitemia and protect from weight loss in 
immunocompromised RAG1KO mice. 2x107 splenocyte cells were adoptively transferred into adult 
RAG1KO mice infected with 1x105 P. chabaudi. (A) Parasitemia in pup recipients, adult recipients, and 
no cell controls (NC) was determined by microscopy from blood smears on day 8 p.i. (B) Mouse weight 
in grams was recorded over 9-day infection period. Data represent 3-4 mice per group from 2 independent 
experiments. Error bars represent SEM and significance was determined by two-tailed t-test *p < 0.05. 
  
 
Based on the reduction in parasite load in recipient RAG1KO mice of both pup and adult 
cells, we next determined the adoptively transferred immune cell populations that could have 
contributed to parasite control in the immunocompromised mice. Therefore, we measured the 
presence of both CD4+ T and  T cells as was performed in physiological studies (Fig. 3 & 4).  
As expected, we observed higher proportions and number of CD4+ T cells in RAG1KO mice that 
received adult splenocytes (Fig. 6A & B), which was reflective of what was observed in 
physiological studies (Fig. 3A & B) above. CD4+ T cells from adult donor mice also produced 
more IFN- as determined by proportion and numbers, when compared to pup donor cells (Fig. 
6C & D). This is consistent with other investigators reporting that classical CD4+ T cells are the 
primary producers of malaria- induced IFN- [24]. 
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FIGURE 6. Adult CD4+ T cells produce more IFN-y after malaria infection. 2x107 splenocytes were 
transferred into RAG1KO mice infected with 1x105 P. chabaudi. (A) proportion and (B) number of CD4+ 
T cells were identified using CD3 and CD4 surface markers. (C) proportions and (D) numbers of CD4+ 
IFN- T cells in pup recipients, adult recipients, and no cell controls (NC). Data represents 3 mice per 
group from 2 independent experiments. Error bars represent SEM and significance was determined by 
two-tailed t-test. *p < 0.05, *** p < 0.001. L.O.D. = Limit of detection 
 
 
 
Pup splenocytes have increased percent and number of   T cells in malaria infection. 
It has been reported that there are higher amounts of CD4+ T cells in infected adult mice, 
and  T cells are higher in young mice [15, 17]. Since we did not observe this initially when 
directly infecting pup and adult mice, due to bigger spleens in the adult mice as mentioned above 
(Fig. 3 and 4A & B), we sought to determine the  T cells in the adoptive transfer RAG1KO 
mouse model. We observed significantly higher proportions and numbers of  T cells in the pup 
cell recipients, than what was observed in the physiological infection between the two groups 
(Fig. 7A & B). Therefore, taken together, these results indicate that pup cell recipients may be 
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protected by the  T cells while the adult cell recipient mice may be protected by conventional 
CD4+ T cells, as well as their production and secretion of IFN-. 
 
 
 
FIGURE 7. Proportions and number of γδ T cells are higher in pup splenocyte recipients after 
malaria infection. 2x107 cells were transferred into RAG1KO mice which were then infected with 1x105 
P. chabaudi. (A) proportion and (B) number of γδ T cells in pup recipients, adult recipients, and no cell 
controls (NC). γδ T cells were identified using anti-mouse CD3 and γδ antibodies. This data represents 3 
mice per group from 2 independent experiments. Error bars represent SEM and significance was 
determined by two-tailed t test, *p < 0.05, ** p < 0.01. L.O.D. = Limit of detection 
 
 
Pup splenocytes increased the natural killer cells in immunocompromised mice in malaria 
infection. 
It has been reported that NK cells significantly contribute to protection against malaria 
(12). Similarly, previous studies have shown that NK cells are increased during early infection 
with experimental malaria (47). We therefore determined if NK cells would also be contributing 
to the protection in pup recipient hosts. As expected, we observed significantly higher 
proportions and numbers of NK cells in the recipients of young splenocytes compared to adult 
splenocytes (Fig. 8A & B). Surprisingly, the no cell control mice also had higher proportions of 
the NK cell population. This data suggests that the immunocompromised mice have higher 
proportions of NK cells due to RAG1KO lacking an adaptive immune response, but it is 
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important to note that they retain their innate immune cell populations (48), therefore the cell 
recipients have their own NK cells prior to the adoptive transfer of splenocytes. The observed 
NK cell-based immunity and amount of NK cells is either maintained or enhanced when cells 
from young mice are transferred but is subsequently decreased upon transfer of adult 
splenocytes. 
 
FIGURE 8. Proportions and numbers of NK cells are higher in pup splenocyte recipients in malaria 
infection. 2x107 cells were transferred into RAG1KO mice, which were infected with 1x105 P. chabaudi. 
(A) proportion and (B) number of NK cells in pup recipients, adult recipients, and no cell controls (NC). 
The NK populations were identified using anti-mouse CD49b and NK1.1 antibodies. These graphs 
represent 3 mice per group from 3 experiments. Error bars represent SEM and significance was 
determined by two-tailed T test. *p < 0.05, ** p < 0.01.  
 
There is no difference in the ability of natural killer cells to respond to IL-2 in both young and 
adult splenocyte recipients. 
 Natural killer cells expand in response to IL-2, since we observed higher proportions of 
NK cells in both the pup cell recipients and no cell recipients, (Fig. 8A & B), we wondered if 
they had similar response to Interleukin 2 (IL-2). To test this, we determined the expression of 
the high-affinity IL-2 receptor alpha chain (CD25) on NK cells in all the groups after malaria 
infection. CD25 has been shown to be upregulated upon NK cell activation, leading to local or 
systemic inflammation, through production of inflammatory cytokines (12, 49). We observed 
lower proportion of CD25 expression in the no cell control which did not reach significant 
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difference, but both pup and adult cell recipients had similar numbers of CD25 expressing NK 
cells. 
 
 
 
FIGURE 9. There is no difference in CD25 expression in NK cells in both pup and adult splenocyte 
recipients. 2x107 cells were transferred into RAG1KO mice, which were infected with 1x105 P. chabaudi. 
(a) proportion and (b) number of NK cells expressing CD25 in pup recipients, adult recipients, and no 
cell controls (NC). The NK populations were identified using antibody markers for CD49b and CD25. 
These graphs represent 3 mice per group from 2 experiments. Error bars represent SEM and significance 
was determined by two-tailed t test. *p < 0.05, ** p < 0.01, *** p <0.001.  
 
 
 
There is no difference in the secretion of IFN- and IL-10 by natural killer cells in splenocyte 
recipients. 
Several studies have demonstrated a crucial role for NK cells in the production of 
cytokines during early murine malaria infections (44, 49, 50). We next tested the functionality of 
NK cells by determining cytokine secretion and cytotoxic capacity. IFN- is significantly 
important during early stages of malaria infection and subsequent parasite clearance (22). Given 
that we observed both higher numbers and proportions of NK cells in pup cell recipients, we 
used intracellular cytokine staining technique to determine IFN- production by the NK cells (24, 
47, 51). We found that despite observing significantly higher proportions and number of NK 
cells in the recipients of young mice splenocytes (Fig. 8A & B), these cells produced similar 
percentages and number of IFN-γ to that produced by the adult cells (Fig. 10A & B). 
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The rapid and robust production of pro-inflammatory cytokines like IFN-γ early in 
malaria infections correlate with more severe clinical symptoms, but better parasite clearance 
(24). In malaria, IFN- secreting cells have been reported to co-produce the anti-inflammatory 
cytokine IL-10 to reduce any potential damage due to inflammation (52, 53). We thus explored 
the secretion of IL-10 by NK cells (54). Similar with what we observed for IFN-, there was no 
difference in the proportion or number of IL-10 secretion by NK cells between the two 
splenocyte recipient groups (Fig. 10C & D). Taken together, these data suggest that NK cells in 
pups may significantly contribute to protection from malaria by secreting both IFN- or IL-10. 
 
 
 
FIGURE 10. There is no defect in NK cell production of IFN-y or IL-10 in pup cell recipients. 2x107 
splenocytes were adoptively transferred into adult RAG1KO mice, infected with 1x105 P. chabaudi. (A) 
Proportion and (B) number of NK cells producing IL-10 in pup recipients, adult recipients, and no cell 
controls (NC). NK cells were identified with markers for CD49b, and cytokines were identified with IFN- 
γ and IL-10 antibodies. Data represent 3 mice per group from 2 experiments. Error bars represent SEM 
and significance was determined by two-tailed t test. 
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Pup splenocytes promote higher numbers of granzyme B production during malaria infection. 
In addition to the well-investigated role for NK cells in cytokine production during 
malaria infection, there is limited but growing evidence to suggest that NK cells may also be 
capable of directly killing Plasmodium-infected cells through cytotoxic activity (11). Therefore, 
we determined the cytotoxic potential of the NK cells through their production of granzyme B 
and Perforin. Pup cells produced significantly more granzyme B compared to adult cells, but 
there was no difference in perforin between the two groups.  
 
FIGURE 11. Pup cells promote increased granzyme B section by the NK cells in RAG1 KO mice. 
2x107 splenocytes were adoptively transferred into adult RAG1KO mice, infected with 1x105 P. chabaudi. 
(A) proportion and (B) number of granzyme B producing NK cells pup recipients, adult recipients, and no 
cell controls (NC). (C) Proportion and (D) number of perforin producing NK cells were identified by 
markers for CD49b and cytotoxic killing was determined by anti-granzyme B and perforin antibodies. 
Data represent 3 mice per group. Error bars represent SEM and significance was determined by two-tailed 
t test. ** p < 0.01. 
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Adult splenocytes promote production of granzyme B and perforin in macrophages during 
malaria infection. 
Since pup cell recipients had higher numbers of the innate lymphocytes (Fig. 8A & B), 
we wondered if normal innate immune cells like macrophages were also contributing to 
protection in pup cells as seen with NK cells above. Therefore, we determined the number 
(CD11b+F4/80+) and activation status (CD11b+MHCII+CD86+) of the macrophages as they are 
important for phagocytosis, clearance of parasite, and disposal of debris from dead infected 
erythrocytes (21). There was no difference in the proportions or number of activated 
macrophages (Fig. 12A & B). 
Similar to NK cells, macrophages also have cytotoxic potential and function through the 
production and secretion of perforin and granzyme B (55). Macrophages in adult donor cells 
produced more granzyme B and perforin than the pup donor cells (Figure 13A & B). Taken 
together, these data suggest that pup cells may functionally depend on NK cells for their 
cytotoxic killing, while adult cells depend on macrophages.  
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FIGURE 12. Adult and pup cells have similar proportions and number of macrophages. 2x107 
splenocytes were adoptively transferred into adult RAG1KO mice, infected with 1x105 P. chabaudi. (A) 
Number of macrophages (B) number of activated macrophages in pup recipients, adult recipients, and no 
cell controls (NC). Macrophages were identified by markers for CD11b, F4/80, and activation was 
determined by markers for MHCII and CD86. Data represent 3 mice per group from 2 experiments. Error 
bars represent SEM and significance was determined by two-tailed t test. 
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FIGURE 13. Macrophages in adult cell recipients express higher numbers of granzyme B and 
perforin. 2x107 splenocytes were adoptively transferred into adult RAG1KO mice, infected with 1x105 P. 
chabaudi. (A) proportion and (B) number of macrophages producing granzyme B. (C) proportion and (D) 
number of macrophages producing perforin in pup recipients, adult recipients, and no cell controls (NC). 
Macrophages were identified by markers for CD11b, and cytotoxic killing was determined by granzyme 
B and perforin antibodies. Data represent 3 mice per group from 2 experiments. Error bars represent SEM 
and significance was determined by two-tailed t test. * p <0.05.  
 
 
 
 
 
 
 
 
 
 
 
 
Pup Adult NC
0
1
2
3
4
5
#
 C
D
1
1
b
+
 P
e
rf
o
ri
n
+
 (
1
0
5
)
Pup Adult NC
0
2
4
6
8
#
 C
D
1
1
b
+
 G
ra
n
z
y
m
e
 B
+
 (
1
0
5
) 
Pup Adult NC
0
2
4
6
8
10
%
 C
D
1
1
b
+
 G
ra
n
z
y
m
e
 B
+
Pup Adult NC
0
2
4
6
8
%
 C
D
1
1
b
+
 P
e
rf
o
ri
n
+
*
DC
A B
 
 
28 
Chapter 4 
 
DISCUSSION 
 
Although the increased efforts toward prevention of malaria spread have resulted in a 
significant decline in disease, most of the progress has focused on reducing further transmission 
of the infection. There is still a considerable lack of knowledge on immune development during 
malaria disease, especially in children. Due to the insufficiently understood parasite biology and 
emergence of drug resistance, there is a growing need for intensive research to better understand 
immunity in order to contribute toward the development of new intervention tools (34). To 
enable progress in these studies, our laboratory established a young rodent model to malaria 
using the P. chabaudi parasite, a well-established rodent parasite strain that has been extensively 
utilized in laboratory settings to study the pathogenesis of malaria (2).  
Although various Plasmodium species differ in their life-cycle characteristics, there is 
significant conservation of both genetic and phenotypic traits between the human malaria 
parasites and their rodent counterparts, therefore making them useful models for studying human 
malaria (2). Due to this, there are several reasons to favor the use of animal models to study 
malaria: (i) animal models allow scientists to investigate the progress of the disease, which is 
more difficult to study in humans, as well as (ii) permit studies of organs to which the parasite 
sequesters, such as the spleen, lungs and brain, and (iii) it is not ethical, practical or financially 
viable to use human volunteers (5, 56).  Overall, there are many parallels between data on P. 
chabaudi experimental malaria and human malaria, which suggests that the use of this species in 
laboratory experiments will continue to yield further important contributions to our 
understanding of the immunobiology of malaria for years to come. With this in mind, our 
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research has utilized a mouse model to investigate differences in immune response between cells 
from young and adult mice that are exposed to a P. chabaudi infection. 
These spleen cells (splenocytes) are comprised of many immune cell populations which 
include all lymphocytes, innate immune cells, and inflammatory mediators. Therefore, it was 
evident that young splenocytes contain cell populations that are capable of transferring protection 
to immunocompromised hosts, based off our previous studies. In this study, we sought to 
investigate the cell populations in the splenocytes of young mice that promote protection against 
malaria infection in comparison to adult cells. 
We first looked at CD4+ T cells, which have been shown to play a central role in the 
immune control of infection with Plasmodium parasites (57). Cell mediated immunity is largely 
T cell-driven, which have been supported in experimental studies that CD4+ T cells rescue 
immunodeficient animals from lethal blood-stage P. chabaudi infection and may also modulate 
susceptibility to re-infection in humans (58, 59). CD4+ T cells control Plasmodium infection in 
multiple ways: (i) cytotoxic responses in the liver, (ii) driving antibody production in the spleen 
and bone marrow through interacting with B cells, and (iii) secreting several cytokines during 
blood-stage infection (58, 60, 61). Our studies indeed show that there is an increased percent and 
number of activated CD4+ T cells in the spleens of 8-week-old adult mice at the peak of malaria 
infection (9 d.p.i). Similar observations were seen with the RAG1 knockout model as well (Fig. 
2 and 5).  
There has been a considerable body of research assessing the role of cytokines in 
protection or risk of malaria, particularly the inflammatory cytokines interferon gamma (IFN-γ) 
and tumor necrosis factor alpha (TNF-α), as well as the regulatory cytokines IL-10, IL-27, and 
TGF- (61-63). With great importance being placed on IFN-, vaccine developers now regard 
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this cytokine production to be the hallmark of effector T cell function for combating malaria 
infection due to its ability to induce innate immune cell function, such as macrophage activation 
(63, 63). Both P. chabaudi and P. falciparum infection generate malaria-specific T cells with the 
ability to make IFN- which has been shown to correlate with protection against P. falciparum 
malaria (61).  
Importantly, there is evidence that children with severe P. falciparum infection have 
lower concentrations of CD4+ T cells secreting IFN- than children with uncomplicated malaria, 
as well as infected adults (60, 65). Interferon is essential for the resolution of primary infection 
by limiting the initial phase of parasite replication, but when left unchecked could heavily 
contribute to the acute symptoms such as fever, nausea, and headache (60, 62), and in extreme 
cases, cerebral malaria (66). In our study there were significantly greater proportion and number 
of IFN- producing CD4+ T cells in adult cell recipients when compared to the pup counterparts 
(Fig. 5). This suggests that older mice not only had more IFN- producing CD4+ T cells when 
compared to younger mice in malaria infection, but that this population may be responsible for 
protecting the adult RAG1KO mice in early malaria infection. But since parasite load was 
similar in both pup and adult cell recipients, we further investigated the cell populations that may 
confer protection to the recipient RAG1KO mice.  
In contrast to conventional T lymphocytes which carry an αβ T-cell receptor, there are 
gamma delta T cells that carry the γδ T-cell receptor. Both of these T cell populations differ in 
their activation, function, and arm of the immune system (being either the innate or adaptive) 
(17, 67). Many of γδ T-cell functions include robust production of inflammatory cytokines, 
cytotoxic killing, as well as immune cell recruitment (16-18). As  T cells are seen in high 
numbers in children than adults (15, 17), it is highly certain that these cells play a role in 
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controlling malaria infection in pup splenocyte recipients due to their ability to rapidly respond 
to foreign invaders prior to antigen presentation (17).  
Despite literature suggesting that there is a greater dependence on  T cells in young 
mice in innate infection (15, 17), this was not observed in our current study when we directly 
infected young mice with P. chabaudi (Fig. 3). But upon adoptive transfer of young and adult 
splenocytes into RAG1KO recipients, we observed significantly greater proportions and numbers 
of  T cells in the pup cell recipients that we did not see in previous studies (Fig. 6). Therefore, 
suggesting that there is an enrichment of  T cells in the splenocytes of young mice that may 
contribute to reduction in parasitemia and weight loss during early infection as previously 
observed in our lab.  
Similar to  T cells, NK cells are also beneficial during the early phase of Plasmodium 
infection as they act as first responders to infection. They act as an effective rapid fire force 
through  (i) rapid response prior to the activation and expansion of antigen specific CD4+ T cells, 
which is crucial towards the early control of parasite pathology (12), and (ii) in a similar manner 
to  T cells, NK cells are relatively promiscuous in their targets (13, 68). Recently published 
studies have also indicated that NK cells are frequently the first cells to directly respond after in 
vitro exposure of human P. falciparum-infected erythrocytes (69). In malaria infections, NK 
cells control pathology through cytolysis and rapid cytokine secretion which activate 
macrophages to eliminate the parasites faster.  
With this in mind, we wanted to look at the presence of NK cells in the recipients of our 
splenocyte cells. Upon adoptive transfer we observed that there were higher proportions and 
numbers of NK cells in recipients of pup splenocytes (Fig. 7). Which is reflective of the idea that 
this population may be playing a protective role in early Plasmodium infection. But surprisingly, 
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we observed that the adult cell recipients had significantly lower percentage and numbers of NK 
cells. Which can be observed when comparing them to the no cell recipients.  
The NK cells expand due to their ability to respond to IL-2, an important cytokine for 
immune cell proliferation. As IL-2 can only function upon upregulation of the high-affinity IL-2 
receptor α chain (CD25), which has been well-documented to be upregulated upon activation, 
allowing NK cells to expand as a result of local or systemic inflammation (55).  In a study 
performed by Korbel it was observed that NK cells upregulated the expression of CD25 upon 
stimulation with iRBCs, which resulted in the rapid production of IFN- as well as the cytolytic 
products perforin and granzyme B (70). This is important because the expression of these 
molecules by NK cells not only indicate cell activation, but their ability to produce important 
mediators that are crucial towards the control of malaria pathology. In our research we 
demonstrated that there was no difference in the expression of CD25 by the NK cells between 
the groups suggesting proper functionality (Fig. 8).  
Cytokines play an important role in immune cell response as described by various 
investigators (24, 54, 55). The cytokines amplify the immune response during the crucial early 
timeframe of infection and ultimately determine pathology as well as disease outcome. In rodent 
malaria, the difference between lethal and non-lethal infections depends on the ability of the 
mouse to mount an IL-12, IFN-y, or TNF- response early in infection. In the presence of 
Plasmodium, observed in both mouse and human studies, NK cell production of IFN-γ has been 
associated with control of parasitemia as well as delayed re-infection (11, 71). In our studies, we 
observed that there was no difference in IFN-γ secretion by NK cells between splenocyte 
recipient groups (Fig. 9). This was interesting due to our observation of a significant decrease in 
NK cells upon adoptive transfer of adult cells in RAG1KO mice, but despite this reduction in 
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amount, their functionality was retained. With this in mind, there is still much debate on whether 
the NK cells are more harmful than helpful due to their ability to rapidly overproduce 
inflammatory cytokines in response to infection, which can also contribute to immunopathology 
(47, 52, 53).  
NK cells also participate by controlling malaria infection through cytotoxic killing. When 
inhibitory signals are reduced, the result is the cytotoxic activation of NK cells and their direct 
interaction with the Plasmodium parasite as well as iRBCs (13). Previous studies conducted by 
Orago et al., provided the initial evidence that there is a direct NK cell cytotoxic response to P. 
falciparum iRBCs in malaria infection (70). Release of perforin and granzymes reflect the 
activation of cytotoxicity in NK cells. Cytolytic products and a number of pro-inflammatory 
cytokines were shown to be elevated in response to P. falciparum infections in African children 
with clinical malaria (72). Here we observed that NK cells from pups produced slightly more 
perforin and granzyme B, compared to the adult cells (Fig. 10).  
Excess circulating inflammatory cytokines can lead to complications and further 
progression of pathology. Therefore, there is a crucial need for control and balance of that 
inflammation.  In order to temper this, NK cells are well-documented in their production of the 
immunoregulatory cytokine, IL-10 (53). Similar to IFN-γ production from NK cells, there was 
no significant difference between the two groups in the production of IL-10 by NK cells (Fig. 9). 
While we observed higher numbers of NK cells in the pup cell recipients, there was no 
difference in their functionality in terms of cytokine secretion. This indicates that the NK cells in 
the pup splenocytes may promote protection through direct killing by secreting granzymes, but 
not cytokine production. NK cells could also function through other mechanisms that have not 
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been established yet. One such mechanism could be induction of cell death in the infected cells 
through Fas mediated apoptosis, even though we did not test this possibility. 
All together we observed, in regard to NK cells and their functionality, that in early 
malaria infection, pup splenocytes had more NK cells early in the infection, and that these cells 
had greater cytotoxic potential than the cells from the adult mice. We also observed that there 
was no difference in the expression of CD25 by the NK cells, nor their ability to produce IL-10 
or IFN-y between the two groups. Some potential possibilities for this observation could be that 
there may be differences in the NK cells activation status and expression of natural cytotoxicity 
triggering receptor 3 (NKp30) or natural-killer receptor group 2, member D (NKG2D) in 
response to early malaria infection. While both receptors have been shown to increase during NK 
cell activation in direct response to iRBCs (73), much has yet to be explored.  
It has previously been demonstrated using in vitro studies that both NKp30 and NKG2D 
bind to the P. falciparum protein Pf EMP1, leading to NK cell activation (73). In particular 
Artavanis-Tsakonas et al.  demonstrated that the engagement of NKG2D stimulates the 
production of cytokines, as well as cytotoxic molecules (73) Traditionally, this receptor is 
viewed as a molecule that mediates direct responses against cellular threats, such as plasmodium. 
Once activated, NKG2D results in (i) signaling for adhesion to the target, (ii) granule 
polarization, (iii) degranularization, and ultimately (iv) the apoptosis of the target cell (74, 75). 
Applying this to our study, future studies will investigate if NKp30 and/ or NKG2D is 
downregulated in the RAG1KO adult cell recipient mice and upregulated in pup cell recipients 
The activation of NK cells is dictated by a balance between positive signals promoted by 
a variety of activating receptors, such as NKG2A, and negative signals provided by inhibitory 
receptors upon interaction with molecules on the target cell. It has been observed that NK cell 
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inhibitory receptors maintain an inactive state through the recognition of constitutively 
expressed “self-molecules” on potential target cells (13). These molecules are used to 
identify non target cells: killer immunoglobulin receptors (KIRs), NKG2A, Ly49 and 
Siglecs, as well as MHCI (76). In particular, major histocompatibility complex (MHC) class I 
acts as an inhibitory signal to NK cells as it signifies that the cells with MHCI are “self”. 
When cells do not have MHCI on their surface, it signifies to NK cells that the cell in 
question has been compromised, resulting in the activation of the NK cells (13, 74). The 
MHC class I binding of inhibitory NK cell receptors may be another potential explanation as to 
why we observed a reduction of NK cells in the adult cell recipients.  
The crosstalk between immune cells is critical for the innate immune system to combat 
the early attacks from pathogenic challenge, particularly the interaction between NK cells and 
macrophages. The macrophage-NK interaction is a major first-line defense against pathogenic 
challenge. Similar to NK cells, macrophages, play an indispensable role during early malaria 
infection through antigen recognition, processing, and presentation (21). Interactions between 
these cell subsets and Plasmodium parasites occur at every stage of the life cycle within the host, 
but most importantly the blood and spleen, where the majority of P. chabaudi pathology occurs 
(22, 23). Blood-stage parasitemia provides many opportunities for antigen presenting cells 
(APCs), such as macrophages, to interact with Plasmodium parasites (4, 30). The direct binding 
of immunoglobulin domains to target cells and the parasite itself are important to initiate 
immunological defenses against pathogens including antigen presentation, phagocytosis, 
cytotoxicity, induction of inflammatory processes and modulation of immune responses (77). 
With emphasis on phagocytosis which results in the internalization of the parasite, and the  
processing and presentation to adaptive immune cells (23, 25). In contrast to pup immune cells 
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which were mostly comprised of NK cells, adult splenocytes were enriched for macrophages 
(Fig. 11). 
Along with NK cells, macrophages are also known to destroy antibody-coated targets via 
antibody-dependent cellular cytotoxicity (ADCC). ADCC is a cell-mediated immune 
defense  mechanism in which an immune cell actively lyses a target, whose membrane-surface 
antigens have been bound by specific antibodies. Once contact is made there is the release of 
cytotoxic factors (perforin and granzyme) that cause the death of the target cell. In malaria 
infection, the target of ADCC is the surface of iRBCs as well as whole parasite (21, 30). 
However, the precise mechanisms by which they carry out this function remains elusive (21). 
Cytolytic products, perforin and granzymes, are critical effectors of the cytolytic immune 
responses. Particularly, granzyme B expression has been shown to be enhanced by agonists of 
toll-like receptor 8 (TLR8), which is documented to directly interact with RNA from P. 
falciparum infected iRBCs (78, 79). In our research we observed that macrophages from adult 
cell recipients produced more perforin and granzyme B, than pup splenocyte recipients (Fig. 12). 
Therefore, it can be concluded that despite similar numbers of macrophages in pup and adult 
splenocyte recipients, pup macrophages may be slightly defective in their cytolytic ability. 
Our research predominately focused on the innate immune response in malaria infection, 
but it is important to note that for sterile immunity to be achieved, it will be dependent on the 
adaptive arm of the immune response. And although immune mechanisms of protection against 
malaria have been extensively studied in both rodent models and humans, they are still not 
completely defined. Protective humoral response against Plasmodium infection can be acquired 
after repeated infections of malaria (3, 59). However, it does not persist over long periods of 
time, is generally incomplete, and requires both exposure to multiple antigenic variants of 
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malaria parasites, and the maturation of the immune system over time (2, 13). And like many 
other infectious diseases, malaria is an inflammatory response-driven disease, and positive 
outcomes to infection depend on finely tuned regulation of the immune responses that leads to 
the effective clearance and control of the parasite over time.  
All these data suggest that pup splenocytes are enriched in  T cells and NK cells. 
However, adult splenocytes were not only enriched in CD4+ T cell but also expressed higher 
proportions of cytotoxic macrophages in the adult spleen cell recipients. Taken together, our 
findings suggest that pup cells are enriched with innate lymphocytes that may promote protection 
against P. chabaudi infection, through reducing parasite burden as well as weight loss. This 
information could be used towards further understanding the childhood innate immune response 
to malaria. Such information would be essential for vaccine design that can help reduce mortality 
rates caused by malaria infection in the most susceptible group. 
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Chapter 5 
 
CONCLUSIONS 
 
 Today, children under 5 years remain the most susceptible group that succumb to malaria 
infections and with the threat of antimalarial resistance, there is an increasing need for new 
methods of counteracting malarial progression. Our data suggests that in a mouse model, pup 
splenocytes are enriched in  T cells and NK cells. We propose that innate lymphocyte 
populations found in pup splenocytes can transfer protection to immunocompromised RAG1KO 
mice, through the observed reduction of parasitemia as well as weight loss in malaria infection. 
In contrast we observed that RAG1KO mice that received adult splenocytes had higher numbers 
of macrophages as well as CD4+ T cells, which were also protective in RAG1KO recipient mice. 
Overall, we propose that despite the differences in the populations of immune cells present in 
pup and adult splenocytes, they are both protective in malaria infection. Further research will 
need to be conducted in order to investigate the functionality of  T cells in malaria infection. 
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